Abstract:Introduction: Women with unilateral breast cancer are at increased risk for having simultaneous cancer of the contralateral breast. Overall, earlier detection of contralateral breast cancer prevents the burden of additional surgery or chemotherapy rounds and is associated with higher overall survival. However, MRI screening for the contralateral breast is seldom done following an initial unilateral breast cancer diagnosis. The purpose of this study is to retrospectively evaluate patients with known, biopsy-proven malignancy who went on to obtain a breast MRI and were later found to have cancer of the contralateral breast. Methods: This was a retrospective study that reviewed the charts of women aged over 18 years who were determined to have synchronous bilateral breast cancer from January 2017 to January 2022 at the University of Florida, Gainesville, FL. The study extracted data from this institution's cancer registry database, which provided information on patients with breast cancer diagnoses. The study conducted a review of mammography (MAM) and MRI imaging reports to ascertain the presence or absence of contralateral breast cancer identified by each respective imaging modality. Surgical pathology reports from the biopsy of the contralateral breast were reviewed to obtain information on the histological type of cancer and TNM (tumor, node, metastasis) staging. Results: Of the 17 cases in which MAM missed contralateral cancer, follow-up MRI detected contralateral malignancy in 12 cases (70.59%) and subsequently changed management, resulting in additional imaging, biopsy, and eventual diagnosis and treatment of contralateral breast cancer. Examining the number of contralateral breast cancers detected by patients who had undergone MAM followed by MRI and those who had only undergone MAM, the study found that the detection rate of contralateral breast cancer from MAM was 45.45% (15/33). The tumor stages of the missed cancers were all T1 or Tis stage with one T1mi, and there was no nodal involvement. Conclusion: In addition to its utility in staging breast cancers, MRI also has the superior ability to detect otherwise undetected contralateral breast malignancy. This retrospective study found that MRI imaging led to a considerable increase in the detection of contralateral cancer. The study found that these undetected contralateral breast cancers by MAM were often of lower staging with no nodal involvement, highlighting the opportunity for MRI to assist in early cancer detection while the patient's prognosis is still good. Its high cost should be balanced with staging and occult malignancy detection utility in future practice.

MRI for breast cancer screening, diagnosis, and treatment

Survival Outcomes of Screening with Breast MRI in Women at Elevated Risk of Breast Cancer

A Study of a Breast MRI Abbreviated Protocol for Breast Neoplasm Screening

Contralateral Breast Screening with Preoperative MRI: Long-Term Outcomes for Newly Diagnosed Breast Cancer

Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis

Magnetic resonance imaging of the breast: Could it be used as a screening test?

The paradox of MRI for breast cancer screening: high-risk and dense breasts—available evidence and current practice

Breast cancer survival following MRI detection in a high‐risk screening program

Breast MRI for Evaluation of Response to Neoadjuvant Therapy

The Role of MRI in Breast Cancer and Breast Conservation Therapy

Detection of Contralateral Malignancies on Breast MRI

Screening Breast MRI Primer: Indications, Current Protocols, and Emerging Techniques

The Breast Cancer Screening and Timing of Breast MRI—Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center

PET/MRI in Breast Cancer

Breast MRI after Mammography Detects Additional Aggressive Cancers, Study Shows.

Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer

Use of Contrast-Enhanced Mammography in Breast Cancer Screening

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

Serial MRI scans help in assessing early response to neoadjuvant chemotherapy and tailoring breast cancer treatment

MRI is Not Exclusive for Breast Cancer Imaging Diagnostics

AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial